Literature DB >> 23021720

Current status and future directions in gastric cancer with peritoneal dissemination.

Gabriel Glockzin1, Pompiliu Piso.   

Abstract

Peritoneal carcinomatosis arising from gastric cancer is mostly associated with poor prognosis. Despite the improvement of survival with modern polychemotherapy, the results are still unsatisfactory. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy might provide an additional therapeutic option for highly selected patients with gastric cancer and peritoneal metastasis leading to improved prognosis. Considering the increased rate of perioperative morbidity and the crucial prognostic role of complete macroscopic cytoreduction, adequate preoperative diagnostics and patient selection are strongly recommended. Further prospective randomized trials are needed to determine the roles of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as part of an interdisciplinary treatment concept.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23021720     DOI： 10.1016/j.soc.2012.07.002

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN： 1055-3207            Impact factor:   3.495


  26 in total

1.  Usefulness of the neutrophil/lymphocyte ratio measured preoperatively as a predictor of peritoneal metastasis in patients with advanced gastric cancer.

Authors:  Yusuke Nakayama; Naoto Gotohda; Hidehito Shibasaki; Shogo Nomura; Takahiro Kinoshita; Ryuichi Hayashi
Journal:  Surg Today       Date:  2014-05-16       Impact factor: 2.549

2.  Tumor-associated mesothelial cells are negative prognostic factors in gastric cancer and promote peritoneal dissemination of adherent gastric cancer cells by chemotaxis.

Authors:  Zhi-Feng Miao; Ting-Ting Zhao; Zhen-Ning Wang; Feng Miao; Ying-Ying Xu; Xiao-Yun Mao; Jian Gao; Hui-Mian Xu
Journal:  Tumour Biol       Date:  2014-03-11

3.  Morphological study and comprehensive cellular constituents of milky spots in the human omentum.

Authors:  Jiu-Yang Liu; Jing-Ping Yuan; Xia-Fei Geng; Ai-Ping Qu; Yan Li
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

4.  Prediction of peritoneal recurrence by the mRNA level of CEA and MMP-7 in peritoneal lavage of gastric cancer patients.

Authors:  Zhen Li; Dewei Zhang; Hao Zhang; Zhifeng Miao; Yuanxin Tang; Gongping Sun; Dongqiu Dai
Journal:  Tumour Biol       Date:  2013-11-27

5.  MicroRNA-106a functions as an oncogene in human gastric cancer and contributes to proliferation and metastasis in vitro and in vivo.

Authors:  Meng Zhu; Ning Zhang; Shuixiang He; Ruirui Yan; Jun Zhang
Journal:  Clin Exp Metastasis       Date:  2016-05-03       Impact factor: 5.150

6.  Transforming growth factor-beta1 signaling blockade attenuates gastric cancer cell-induced peritoneal mesothelial cell fibrosis and alleviates peritoneal dissemination both in vitro and in vivo.

Authors:  Zhi-Feng Miao; Ting-Ting Zhao; Zhen-Ning Wang; Feng Miao; Ying-Ying Xu; Xiao-Yun Mao; Jian Gao; Jian-Hua Wu; Xing-Yu Liu; Yi You; Hao Xu; Hui-Mian Xu
Journal:  Tumour Biol       Date:  2013-12-18

7.  Peritoneal dissemination in early gastric cancer: importance of the lymphatic route.

Authors:  Masao Yoshida; Takashi Sugino; Kimihide Kusafuka; Takashi Nakajima; Rie Makuuchi; Masanori Tokunaga; Yutaka Tanizawa; Etsuro Bando; Taiichi Kawamura; Masanori Terashima; Noboru Kawata; Masaki Tanaka; Naomi Kakushima; Kohei Takizawa; Hiroyuki Ono
Journal:  Virchows Arch       Date:  2016-05-25       Impact factor: 4.064

8.  Conventional cytology is not beneficial for predicting peritoneal recurrence after curative surgery for gastric cancer: results of a prospective clinical study.

Authors:  Ki-Kwan Kang; Hoon Hur; Cheul Su Byun; Young Bae Kim; Sang-Uk Han; Yong Kwan Cho
Journal:  J Gastric Cancer       Date:  2014-03-31       Impact factor: 3.720

9.  Diagnostic value of negative enrichment and immune fluorescence in situ hybridization for intraperitoneal free cancer cells of gastric cancer.

Authors:  Anqiang Wang; Zhongwu Li; Qian Wang; Yali Bai; Xin Ji; Tao Fu; Ke Ji; Yanwen Xue; Tingxu Han; Xiaojiang Wu; Ji Zhang; Yingjie Yang; Guobin Xu; Zhaode Bu; Jiafu Ji
Journal:  Chin J Cancer Res       Date:  2019-12       Impact factor: 5.087

10.  Expression of MACC1 and c-Met in human gastric cancer and its clinical significance.

Authors:  Tiankang Guo; Jingyu Yang; Jibin Yao; Yongbin Zhang; Mingxu Da; Yaoxing Duan
Journal:  Cancer Cell Int       Date:  2013-12-10       Impact factor: 5.722
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.